Product image of Metaraminol Torbay Pharmaceuticals (Metaraminol) supplied by GNH India

Metaraminol Torbay Pharmaceuticals

Active Ingredient:
Metaraminol
Origin:
EU

Metaraminol Torbay Pharmaceuticals (Metaraminol)

Metaraminol, the active ingredient in Metaraminol Torbay Pharmaceuticals, is a sympathomimetic amine presented as an injectable solution for intravenous use. It is employed to raise blood pressure in acute hypotensive states and various forms of shock.
GNH India supplies Metaraminol Torbay Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Torbay Pharmaceuticals Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metaraminol acts as a vasopressor within the sympathomimetic amine class, increasing vascular tone in critical circulatory conditions.

  • Hypotension: restores adequate arterial pressure in patients with acute low‑blood‑pressure episodes.
  • Shock: supports systemic vascular resistance during distributive or hypovolemic shock.
  • Severe bleeding: maintains perfusion pressure while volume resuscitation is ongoing.

How It Works

  • Metaraminol binds directly to alpha‑1 adrenergic receptors on vascular smooth muscle, triggering vasoconstriction. This action raises systemic vascular resistance and arterial pressure without significant beta‑adrenergic stimulation, thereby improving perfusion in hypotensive or shock states.

Side Effects

Metaraminol may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects

  • Headache: mild to moderate pain in the head region.
  • Nausea: feeling of queasiness or urge to vomit.
  • Tachycardia: increased heart rate.
  • Palpitations: awareness of rapid or irregular heartbeat.
  • Anxiety: heightened nervousness or restlessness.
  • Flushing: reddening of the skin, especially on the face.

Serious or Rare Side Effects

  • Arrhythmia: abnormal heart rhythm that may be life‑threatening.
  • Myocardial ischemia: reduced blood flow to the heart muscle.
  • Severe hypertension: dangerously high blood pressure.
  • Tissue necrosis at injection site: localized tissue death due to extravasation.
  • Allergic reaction: rash, itching, swelling, or anaphylaxis.
  • Pulmonary edema: fluid accumulation in the lungs.

Precautions & Warnings

When using Metaraminol, clinicians should observe several safety measures.

  • Monitor blood pressure: avoid excessive hypertension.
  • Assess cardiac status: watch for arrhythmias or ischemia.
  • Use caution in peripheral vascular disease: risk of compromised blood flow.
  • Avoid rapid bolus administration: deliver as controlled infusion.
  • Pregnancy and lactation: safety unknown; use only if essential.
  • Store below 25°C: keep in original container, protect from light and moisture.

Avoid Interactions

Metaraminol can interact with other medications, requiring attention to the level of risk.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors: may precipitate hypertensive crisis.
  • Beta‑blockers: can blunt compensatory tachycardia.
  • Tricyclic antidepressants: additive vasoconstrictive effect.

Moderate Interactions (Monitor Closely)

  • Other vasopressors: additive pressor effect may cause severe hypertension.
  • Sympathomimetic agents: increased cardiovascular stress.
  • Calcium channel blockers: potential alteration of vascular tone.

Frequently Asked Questions

Metaraminol Torbay Pharmaceuticals is a vasopressor indicated for the rapid correction of acute hypotension and for supporting blood pressure in various forms of shock, such as distributive or hypovolemic shock, by increasing systemic vascular resistance.

Metaraminol acts as a direct alpha‑1 adrenergic receptor agonist. Stimulation of these receptors on vascular smooth muscle produces vasoconstriction, which elevates systemic vascular resistance and raises arterial blood pressure without significant beta‑adrenergic activity.

The dose of Metaraminol is individualized by the prescribing clinician based on the patient’s hemodynamic status, response to therapy, and clinical setting. Specific dosing regimens are determined at the point of care and are not standardized in public product literature.

Safety data for Metaraminol in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should be used only when the potential benefit justifies any potential risk to the fetus or nursing infant.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and the necessary import documentation.

Compared with agents such as norepinephrine, Metaraminol provides direct alpha‑1 stimulation with minimal beta‑adrenergic activity, which may result in less tachycardia while achieving comparable pressor effects. Choice of agent depends on the clinical scenario, patient comorbidities, and physician preference.

Metaraminol injectable solution should be stored below 25 °C, protected from light and moisture, and kept in its original sealed container. The product must not be frozen or shaken before administration.

Metaraminol is administered intravenously, either as a controlled infusion or a slow bolus, under continuous hemodynamic monitoring. The exact administration technique and rate are determined by the treating clinician based on the patient’s condition.

Serious adverse events include severe hypertension, life‑threatening arrhythmias, myocardial ischemia, tissue necrosis at the injection site, and rare allergic reactions such as anaphylaxis. Immediate medical attention is required if any of these occur.

Metaraminol is contraindicated in individuals with known hypersensitivity to the drug, uncontrolled hypertension, severe peripheral vascular disease, or any condition where a rapid increase in vascular tone is contraindicated, unless a clinician determines that the therapeutic benefit outweighs the risk.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metaraminol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT